Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,861 | 421 | 51.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,237 | 13 | 43.8% |
| Consulting Fee | $500.00 | 1 | 2.4% |
| Education | $298.61 | 16 | 1.4% |
| Travel and Lodging | $160.08 | 4 | 0.8% |
| Gift | $39.72 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $11,333 | 76 | $0 (2024) |
| Biogen, Inc. | $1,179 | 47 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,025 | 29 | $0 (2023) |
| GENZYME CORPORATION | $839.81 | 21 | $0 (2022) |
| Promius Pharma LLC | $621.18 | 2 | $0 (2017) |
| AbbVie Inc. | $506.37 | 36 | $0 (2023) |
| UCB, Inc. | $491.74 | 21 | $0 (2022) |
| Amgen Inc. | $476.00 | 17 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $450.73 | 22 | $0 (2023) |
| Allergan, Inc. | $293.14 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.51 | 12 | EMD Serono, Inc. ($202.04) |
| 2023 | $1,471 | 63 | EMD Serono, Inc. ($467.21) |
| 2022 | $1,327 | 57 | ABBVIE INC. ($203.28) |
| 2021 | $1,366 | 71 | AbbVie Inc. ($175.32) |
| 2020 | $1,620 | 41 | EMD Serono, Inc. ($1,008) |
| 2019 | $8,977 | 66 | EMD Serono, Inc. ($7,472) |
| 2018 | $3,719 | 77 | EMD Serono, Inc. ($1,702) |
| 2017 | $2,359 | 70 | Promius Pharma LLC ($621.18) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.58 | General |
| 08/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.99 | General |
| 08/08/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: AMANTADINE | ||||||
| 07/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| 07/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.32 | General |
| 06/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.24 | General |
| 06/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.52 | General |
| 05/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.15 | General |
| 03/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.54 | General |
| 02/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $148.93 | General |
| Category: Neurology | ||||||
| 01/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.65 | General |
| 12/11/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $3.62 | General |
| Category: Neurology | ||||||
| 11/21/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: Neurology | ||||||
| 11/13/2023 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Neurology | ||||||
| 11/08/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $110.23 | General |
| 11/06/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $30.24 | General |
| Category: NEUROLOGY | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Neurology | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: Neurology | ||||||
| 10/26/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Neurology | ||||||
| 10/12/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Parkinson's Disease | ||||||
| 10/05/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: CNS | ||||||
| 10/02/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $2.23 | General |
| Category: Neurology | ||||||
| 08/31/2023 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS, EXSERVAN | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 534 | 648 | $171,017 | $69,525 |
| 2022 | 8 | 591 | 725 | $198,617 | $83,561 |
| 2021 | 8 | 574 | 705 | $188,325 | $80,326 |
| 2020 | 9 | 587 | 701 | $193,215 | $66,866 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 261 | $55,624 | $22,552 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 107 | 116 | $33,118 | $13,523 | 40.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 70 | 70 | $28,605 | $11,526 | 40.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 22 | 22 | $17,584 | $7,581 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 84 | $12,126 | $5,585 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,783 | $4,521 | 35.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 16 | 16 | $5,881 | $2,065 | 35.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 17 | 27 | $4,917 | $2,028 | 41.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 12 | 13 | $379.34 | $143.68 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 266 | $57,276 | $23,938 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 132 | 150 | $43,033 | $18,966 | 44.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 89 | 89 | $36,369 | $14,489 | 39.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 25 | 25 | $19,982 | $8,834 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 85 | $12,271 | $5,618 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $12,127 | $4,566 | 37.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 29 | 50 | $9,106 | $3,902 | 42.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 23 | 23 | $8,453 | $3,249 | 38.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 256 | $54,559 | $23,139 | 42.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 122 | 139 | $39,685 | $17,770 | 44.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 96 | 96 | $39,266 | $15,365 | 39.1% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 18 | 18 | $14,387 | $6,504 | 45.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 97 | $14,003 | $6,388 | 45.6% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 28 | 28 | $10,291 | $4,282 | 41.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 29 | 49 | $8,924 | $4,069 | 45.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $7,211 | $2,808 | 38.9% |
About Dr. Susan Blue, M.D
Dr. Susan Blue, M.D is a Specialist healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578540431.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Blue, M.D has received a total of $21,096 in payments from pharmaceutical and medical device companies, with $257.51 received in 2024. These payments were reported across 457 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,861).
As a Medicare-enrolled provider, Blue has provided services to 2,286 Medicare beneficiaries, totaling 2,779 services with total Medicare billing of $300,278. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Fort Worth, TX
- Active Since 12/30/2005
- Last Updated 05/11/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578540431
Products in Payments
- Mavenclad (Biological) $7,306
- Rebif (Biological) $1,989
- Mavenclad (Drug) $1,106
- Zembrace (Drug) $621.18
- AUBAGIO (Drug) $554.36
- TYSABRI (Biological) $489.93
- TECFIDERA (Drug) $431.88
- Aimovig (Biological) $359.50
- COPAXONE (Drug) $328.30
- KESIMPTA (Drug) $304.56
- RYTARY (Drug) $286.58
- GOCOVRI (Drug) $273.97
- QULIPTA (Drug) $237.24
- AJOVY (Drug) $226.90
- AJOVY (Biological) $226.46
- UBRELVY (Drug) $225.76
- Briviact (Drug) $212.70
- APTIOM (Drug) $210.42
- OXTELLAR XR (Drug) $207.14
- NUPLAZID (Drug) $196.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fort Worth
Jay Roberts, D.o, D.O
Specialist — Payments: $119,796
Richard Vigness, M. D, M. D
Specialist — Payments: $90,363
Dr. Louis Strock, M.d, M.D
Specialist — Payments: $71,191
Dr. Adam Smith, D.o, D.O
Specialist — Payments: $38,927
Charles Secrest, Md, MD
Specialist — Payments: $28,015
Steven Singleton, M.d, M.D
Specialist — Payments: $24,056